Showing 881 - 900 results of 28,416 for search '(( 50 ((n decrease) OR (a decrease)) ) OR ( 100 ((de decrease) OR (nn decrease)) ))', query time: 1.09s Refine Results
  1. 881
  2. 882
  3. 883
  4. 884
  5. 885
  6. 886

    Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner by Khondoker Alam (1443499)

    Published 2017
    “…Pretreatment with bortezomib (50–250 nM, 2–7 h) significantly decreased transport of [<sup>3</sup>H]CCK-8, a specific OATP1B3 substrate, in HEK293-OATP1B3 and human sandwich-cultured hepatocytes (SCH). …”
  7. 887

    eNOS phosphorylation increased intracellular ROS generation and decreased cell viability in BH4-depleted cells. by Hu Peng (396074)

    Published 2015
    “…(B) VEGF-mediated eNOS phosphorylation resulted a significant ROS increase in eNOS overexpressing HEK 293 cells (n = 5 fields, *, <i>p</i> < 0.05). …”
  8. 888
  9. 889
  10. 890
  11. 891
  12. 892
  13. 893
  14. 894
  15. 895
  16. 896
  17. 897

    DataSheet2_Loss-of-function N178T variant of the human P2Y4 receptor is associated with decreased severity of coronary artery disease and improved glucose homeostasis.ZIP by Michael Horckmans (14206388)

    Published 2022
    “…Regarding fasting plasma parameters, the N178T variant was associated with a lower concentration of glucose. …”
  18. 898

    DataSheet1_Loss-of-function N178T variant of the human P2Y4 receptor is associated with decreased severity of coronary artery disease and improved glucose homeostasis.ZIP by Michael Horckmans (14206388)

    Published 2022
    “…Regarding fasting plasma parameters, the N178T variant was associated with a lower concentration of glucose. …”
  19. 899

    DataSheet3_Loss-of-function N178T variant of the human P2Y4 receptor is associated with decreased severity of coronary artery disease and improved glucose homeostasis.ZIP by Michael Horckmans (14206388)

    Published 2022
    “…Regarding fasting plasma parameters, the N178T variant was associated with a lower concentration of glucose. …”
  20. 900

    DataSheet4_Loss-of-function N178T variant of the human P2Y4 receptor is associated with decreased severity of coronary artery disease and improved glucose homeostasis.ZIP by Michael Horckmans (14206388)

    Published 2022
    “…Regarding fasting plasma parameters, the N178T variant was associated with a lower concentration of glucose. …”